ArticleClinical case reports2022

Long-term (>5-year) survivors among unresectable or metastatic cancer patients treated with zoledronate-activated killer cells: Seven case reports.

Yoshiyuki YamaguchiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.